A new kind of carrier-free nanoparticle was developed to simultaneously deliver chemotherapeutic drug, cytolytic peptide, and anti-TOX small interfering RNA using a fluorinated prodrug strategy.
[Advanced Materials]
Home Newsletters Immune Regulation News Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier-Free Nanoassembly...
